Generation of reactive oxygen species and activity of platelet-activating factor acetylhydrolase in human monocyte-derived macrophages. 1994

S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
Research Centre for Vascular Biology and Medicine Erfurt, University of Jena, Germany.

Monocytes were prepared from healthy human volunteers and were allowed to differentiate into macrophages by adhesion to plastic surface and cultured over 7 days in presence of either 10% fetal calf serum (FCS), human control serum or serum from hyperlipaemic patients. Hyperlipaemic serum stimulated the differentiation (measured as an increase in cellular protein and DNA content) to a higher extent when compared to control serum and FCS. With all sera a marked increase of the cellular activity of the enzyme platelet-activating factor acetylhydrolase (PAF-AH) and a tremendous decrease in the capacity of cells to generate reactive oxygen species (ROS) was observed. After seven days of culture the increase in PAH-AH activity was about 19-fold with hyperlipaemic serum, 11-fold with control serum and 6-fold with FCS. During the same period of time ROS generation measured as zymosan-induced chemiluminescence decreased by about 98% and no significant differences between the three types of serum were found. The results indicate that the activity of PAF-AH and the capacity of ROS generation which are both assumed to play an important role in the oxidation of low-density lipoproteins (LDL) and thus in the development of atherosclerosis, change in opposite direction during the differentiation of blood monocytes into macrophages, and that hyperlipaemic serum stimulates PAF-AH activity but not ROS generation.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D043203 1-Alkyl-2-acetylglycerophosphocholine Esterase A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA. PAF Acetylhydrolase,Platelet-Activating Factor Hydrolase,Lipoprotein-Associated Phospholipase A(2),Lipoprotein-Associated Phospholipase A2,Lp-PLA(2),Lp-PLA2,PAF 2-Acetylhydrolase,PAF 2-Acylhydrolase,PAF Acetylhydrolase II,Platelet-activating Factor Acetylhydrolase IB,1 Alkyl 2 acetylglycerophosphocholine Esterase,2-Acetylhydrolase, PAF,Acetylhydrolase II, PAF,Acetylhydrolase, PAF,Esterase, 1-Alkyl-2-acetylglycerophosphocholine,Factor Hydrolase, Platelet-Activating,Hydrolase, Platelet-Activating Factor,Lipoprotein Associated Phospholipase A2,Lp PLA2,PAF 2 Acetylhydrolase,PAF 2 Acylhydrolase,Phospholipase A2, Lipoprotein-Associated,Platelet Activating Factor Hydrolase,Platelet activating Factor Acetylhydrolase IB

Related Publications

S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
June 1997, Thrombosis research,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
January 2003, Journal of immunology (Baltimore, Md. : 1950),
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
June 1990, The Journal of biological chemistry,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
November 1988, Biochemical and biophysical research communications,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
December 2003, The Journal of clinical endocrinology and metabolism,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
November 1993, The Journal of clinical endocrinology and metabolism,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
September 2017, Pathogens and disease,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
January 1996, Advances in experimental medicine and biology,
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
January 1999, Methods in molecular biology (Clifton, N.J.),
S Russwurm, and S Krause, and L Finkelberg, and K Rühling, and U Schauer, and W Lösche
January 1991, Methods in enzymology,
Copied contents to your clipboard!